You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 269 No. 17, May 5, 1993 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Clinical Investigation
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Corticotropin-Releasing Hormone Stimulation Following Low-Dose Dexamethasone Administration

A New Test to Distinguish Cushing's Syndrome From Pseudo-Cushing's States

Jack A. Yanovski, MD, PhD; Gordon B. Cutler, Jr, MD; George P. Chrousos, MD; Lynnette K. Nieman, MD

JAMA. 1993;269(17):2232-2238.


Abstract

Objective.
—The biochemical and phenotypic presentation of mild hypercortisolism in Cushing's syndrome is often indistinguishable from that seen in pseudo-Cushing's states such as depression. Both dexamethasone suppression and corticotropin-releasing hormone (CRH) stimulation tests have been used individually to distinguish these conditions, but neither approach has achieved a diagnostic accuracy greater than 85%. Therefore, we sought to develop a combined dexamethasone-CRH test that would take advantage of the altered sensitivity of patients with Cushing's syndrome to both dexamethasone and CRH and would achieve greater accuracy in the diagnosis of Cushing's syndrome.

Design.
—Prospective cohort study.

Setting.
—Tertiary care research hospital.

Patients.
—A total of 58 adults referred for evaluation of mild hypercortisolism (urine free cortisol level <1000 nmol/d). The diagnosis of Cushing's syndrome was confirmed at surgery in 39 patients. The diagnosis of a pseudo-Cushing's state was made in 19 patients on the basis of extended follow-up (mean, 28 months) without progression of cushingoid features.

Intervention.
—The low-dose dexamethasone suppression test, the CRH stimulation test, and the CRH stimulation test started 2 hours after completion of low-dose dexamethasone suppression (the dexamethasone-CRH test) were performed in all patients.

Main Outcome Measures.
—Sensitivity, specificity, and accuracy of the three procedures for diagnosis of Cushing's syndrome were calculated from plasma corticotropin, plasma cortisol, urine free cortisol, and urine 17-hydroxycorticosteroid values.

Results.
—The low-dose dexamethasone suppression test had 74% specificity, 69% sensitivity, and 71% diagnostic accuracy, using the standard criterion (17-hydroxycorticosteroid excretion level >11.0 µmol/d on the second day of dexamethasone administration). With a urine free cortisol criterion for Cushing's syndrome of greater than 100 nmol/d, the low-dose dexamethasone suppression test had 100% specificity, 56% sensitivity, and 71% diagnostic accuracy. The CRH stimulation test without dexamethasone pretreatment had 100% specificity, 64% sensitivity, and 76% diagnostic accuracy. The diagnostic accuracy of the dexamethasone-CRH test for Cushing's syndrome was significantly greater than the accuracy of either the low-dose dexamethasone test or the CRH test alone (P<.01). A plasma cortisol concentration greater than 38 nmol/L measured 15 minutes after the administration of CRH correctly identified all cases of Cushing's syndrome and all cases of pseudo-Cushing's states (100% specificity, sensitivity, and diagnostic accuracy).

Conclusion.
—The dexamethasone-CRH test is a more accurate test to distinguish Cushing's syndrome from pseudo-Cushing's states in patients with mild hypercortisolism.

(JAMA. 1993;269:2232-2238)



Author Affiliations

From the Developmental Endocrinology Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Md.


Footnotes

Reprint requests to Bldg 10, Room 10N262, National Institutes of Health, Bethesda, MD 20892 (Dr Yanovski).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Human corticotropin releasing hormone test performance in the differential diagnosis between Cushing's disease and pseudo-Cushing state is enhanced by combined ACTH and cortisol analysis
Arnaldi et al.
Eur J Endocrinol 2009;160:891-898.
ABSTRACT | FULL TEXT  

The combined low-dose dexamethasone suppression corticotropin-releasing hormone test as a tool to rule out Cushing's syndrome
Reimondo et al.
Eur J Endocrinol 2008;159:569-576.
ABSTRACT | FULL TEXT  

Severe Obesity Confounds the Interpretation of Low-Dose Dexamethasone Test Combined with the Administration of Ovine Corticotrophin-Releasing Hormone in Childhood Cushing Syndrome
Batista et al.
J. Clin. Endocrinol. Metab. 2008;93:4323-4330.
ABSTRACT | FULL TEXT  

The Diagnosis of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline
Nieman et al.
J. Clin. Endocrinol. Metab. 2008;93:1526-1540.
ABSTRACT | FULL TEXT  

Accuracy of Diagnostic Tests for Cushing's Syndrome: A Systematic Review and Metaanalyses
Elamin et al.
J. Clin. Endocrinol. Metab. 2008;93:1553-1562.
ABSTRACT | FULL TEXT  

Limitations of nocturnal salivary cortisol and urine free cortisol in the diagnosis of mild Cushing's syndrome
Kidambi et al.
Eur J Endocrinol 2007;157:725-731.
ABSTRACT | FULL TEXT  

Reevaluation of the Combined Dexamethasone Suppression-Corticotropin-Releasing Hormone Test for Differentiation of Mild Cushing's Disease from Pseudo-Cushing's Syndrome
Gatta et al.
J. Clin. Endocrinol. Metab. 2007;92:4290-4293.
ABSTRACT | FULL TEXT  

Hypothalamic-Pituitary-Adrenal Axis Activity in Obese Men with and without Sleep Apnea: Effects of Continuous Positive Airway Pressure Therapy
Vgontzas et al.
J. Clin. Endocrinol. Metab. 2007;92:4199-4207.
ABSTRACT | FULL TEXT  

Cyclic Cushing's syndrome: a clinical challenge
Meinardi et al.
Eur J Endocrinol 2007;157:245-254.
ABSTRACT | FULL TEXT  

The Dexamethasone-Suppressed Corticotropin-Releasing Hormone Test for the Diagnosis of Cushing's Syndrome: What Have We Learned in 14 Years?
Nieman
J. Clin. Endocrinol. Metab. 2007;92:2876-2878.
FULL TEXT  

Dexamethasone-Suppressed Corticotropin-Releasing Hormone Stimulation Test for Diagnosis of Mild Hypercortisolism
Erickson et al.
J. Clin. Endocrinol. Metab. 2007;92:2972-2976.
ABSTRACT | FULL TEXT  

Cushing's Syndrome: Important Issues in Diagnosis and Management
Findling and Raff
J. Clin. Endocrinol. Metab. 2006;91:3746-3753.
ABSTRACT | FULL TEXT  

Comparison of the Dexamethasone-Suppressed Corticotropin-Releasing Hormone Test and Low-Dose Dexamethasone Suppression Test in the Diagnosis of Cushing's Syndrome
Martin et al.
J. Clin. Endocrinol. Metab. 2006;91:2582-2586.
ABSTRACT | FULL TEXT  

Evaluation of the effectiveness of midnight serum cortisol in the diagnostic procedures for Cushing's syndrome
Reimondo et al.
Eur J Endocrinol 2005;153:803-809.
ABSTRACT | FULL TEXT  

Reproducibility of Nighttime Salivary Cortisol and Its Use in the Diagnosis of Hypercortisolism Compared with Urinary Free Cortisol and Overnight Dexamethasone Suppression Test
Viardot et al.
J. Clin. Endocrinol. Metab. 2005;90:5730-5736.
ABSTRACT | FULL TEXT  

Effect of Pioglitazone on Adrenocorticotropic Hormone and Cortisol Secretion in Cushing's Disease
Suri and Weiss
J. Clin. Endocrinol. Metab. 2005;90:1340-1346.
ABSTRACT | FULL TEXT  

Pituitary disease: presentation, diagnosis, and management
Levy
J. Neurol. Neurosurg. Psychiatry 2004;75:iii47-iii52.
FULL TEXT  

Jugular Venous Sampling: An Alternative to Petrosal Sinus Sampling for the Diagnostic Evaluation of Adrenocorticotropic Hormone-Dependent Cushing's Syndrome
Ilias et al.
J. Clin. Endocrinol. Metab. 2004;89:3795-3800.
ABSTRACT | FULL TEXT  

The Low-Dose Dexamethasone Suppression Test: A Reevaluation in Patients with Cushing's Syndrome
Findling et al.
J. Clin. Endocrinol. Metab. 2004;89:1222-1226.
ABSTRACT | FULL TEXT  

Diagnosis and Complications of Cushing's Syndrome: A Consensus Statement
Arnaldi et al.
J. Clin. Endocrinol. Metab. 2003;88:5593-5602.
ABSTRACT | FULL TEXT  

Occult Cushing's Syndrome in Type-2 Diabetes
Catargi et al.
J. Clin. Endocrinol. Metab. 2003;88:5808-5813.
ABSTRACT | FULL TEXT  

Midnight Salivary Cortisol Versus Urinary Free and Midnight Serum Cortisol as Screening Tests for Cushing's Syndrome
Putignano et al.
J. Clin. Endocrinol. Metab. 2003;88:4153-4157.
ABSTRACT | FULL TEXT  

A Physiologic Approach to Diagnosis of the Cushing Syndrome
Raff and Findling
ANN INTERN MED 2003;138:980-991.
FULL TEXT  

Accuracy of Bilateral Inferior Petrosal or Cavernous Sinuses Sampling in Predicting the Lateralization of Cushing's Disease Pituitary Microadenoma: Influence of Catheter Position and Anatomy of Venous Drainage
Lefournier et al.
J. Clin. Endocrinol. Metab. 2003;88:196-203.
ABSTRACT | FULL TEXT  

Nighttime Salivary Cortisol: A Useful Test for the Diagnosis of Cushing's Syndrome
Papanicolaou et al.
J. Clin. Endocrinol. Metab. 2002;87:4515-4521.
ABSTRACT | FULL TEXT  

Chronic Insomnia Is Associated with Nyctohemeral Activation of the Hypothalamic-Pituitary-Adrenal Axis: Clinical Implications
Vgontzas et al.
J. Clin. Endocrinol. Metab. 2001;86:3787-3794.
ABSTRACT | FULL TEXT  

Middle-Aged Men Show Higher Sensitivity of Sleep to the Arousing Effects of Corticotropin-Releasing Hormone Than Young Men: Clinical Implications
Vgontzas et al.
J. Clin. Endocrinol. Metab. 2001;86:1489-1495.
ABSTRACT | FULL TEXT  

The Desmopressin Test in the Differential Diagnosis between Cushing's Disease and Pseudo-Cushing States
Moro et al.
J. Clin. Endocrinol. Metab. 2000;85:3569-3574.
ABSTRACT | FULL TEXT  

Cortisol Production Rates in Subjects with Suspected Cushing's Syndrome: Assessment by Stable Isotope Dilution Methodology and Comparison to Other Diagnostic Methods
Samuels et al.
J. Clin. Endocrinol. Metab. 2000;85:22-28.
ABSTRACT | FULL TEXT  

Cavernous Sinus Sampling Is Highly Accurate in Distinguishing Cushing's Disease from the Ectopic Adrenocorticotropin Syndrome and in Predicting Intrapituitary Tumor Location
Graham et al.
J. Clin. Endocrinol. Metab. 1999;84:1602-1610.
ABSTRACT | FULL TEXT  

The Diagnosis and Differential Diagnosis of Cushing's Syndrome and Pseudo-Cushing's States
Newell-Price et al.
Endocr. Rev. 1998;19:647-672.
ABSTRACT | FULL TEXT  

Menstrual Abnormalities in Women with Cushing's Disease Are Correlated with Hypercortisolemia Rather Than Raised Circulating Androgen Levels
Lado-Abeal et al.
J. Clin. Endocrinol. Metab. 1998;83:3083-3088.
ABSTRACT | FULL TEXT  

High Intensity Exercise Promotes Escape of Adrenocorticotropin and Cortisol from Suppression by Dexamethasone: Sexually Dimorphic Responses
Deuster et al.
J. Clin. Endocrinol. Metab. 1998;83:3332-3338.
ABSTRACT | FULL TEXT  

Comment on High Urinary Free Cortisol Excretion in a Patient with Psychogenic Polydipsia
Friedman and Papanicolaou
J. Clin. Endocrinol. Metab. 1998;83:3378a-3378.
FULL TEXT  

Plasma Levels of Corticotropin-Releasing Hormone in the Inferior Petrosal Sinuses of Healthy Volunteers, Patients with Cushing's Syndrome, and Patients with Pseudo-Cushing States
Yanovski et al.
J. Clin. Endocrinol. Metab. 1998;83:1485-1488.
ABSTRACT | FULL TEXT  

A Single Midnight Serum Cortisol Measurement Distinguishes Cushing's Syndrome from Pseudo-Cushing States
Papanicolaou et al.
J. Clin. Endocrinol. Metab. 1998;83:1163-1167.
ABSTRACT | FULL TEXT  

The Dexamethasone-Suppressed Corticotropin-Releasing Hormone Stimulation Test Differentiates Mild Cushing's Disease from Normal Physiology
Yanovski et al.
J. Clin. Endocrinol. Metab. 1998;83:348-352.
ABSTRACT | FULL TEXT  

Use of Methodological Standards in Diagnostic Test Research: Getting Better but Still Not Good
Reid et al.
JAMA 1995;274:645-651.
ABSTRACT  

Cushing's Syndrome
Orth
NEJM 1995;332:791-803.
FULL TEXT  

Loperamide to Diagnose Cushing's Syndrome
Ambrosi et al.
JAMA 1993;270:2301-2302.
ABSTRACT  

Loperamide to Diagnose Cushing's Syndrome-Reply
Yanovski
JAMA 1993;270:2302-2302.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1993 American Medical Association. All Rights Reserved.